Tagged with Laboratorios Rubió

Catalan Momentum Continues

Spain Catalan Momentum Continues

Spain After decades of investment, Catalonia has secured its healthcare and life sciences hub status, accounting for more than half of Spain’s pharma exports and with more clinical trials than any other region. The birthplace of many of the country’s pharma success stories, Catalonia boasts a strong scientific output by European…

Marc Comas – Managing Director, Accord Healthcare Iberia

Spain Marc Comas – Managing Director, Accord Healthcare Iberia

Spain Accord’s Marc Comas highlights the company’s presence in Spain with leading oncology products, three biosimilars and investment in specialty pharma. He shares his views on the COVID pandemic, the future of the supply chain, the importance of Spain, Barcelona’s attractiveness for the pharma industry, and explains why Accord will be…

Carlos Rubió – Executive President, Laboratorios Rubió

Spain Carlos Rubió – Executive President, Laboratorios Rubió

Spain The executive president of Laboratorios Rubió, Carlos Rubió, analyses the fundamentals behind the Catalan company’s double-digit growth, its international expansion plan, which includes the United States, the doubling of capacity at their Castellbisbal plant, and the challenges of the Spanish market. A producer of hydroxychloroquine, Laboratorios Rubió experienced skyrocketing demand…

Carlos Rubió – Executive President, Laboratorios Rubió, Spain

Spain Carlos Rubió – Executive President, Laboratorios Rubió, Spain

Spain Carlos Rubió, executive president of Laboratorios Rubió, gives an overview of the company’s early years and his priorities now to make the company a larger player on the international scene. Furthermore, he highlights the need to increase the company´s size through JVs, possible M&As and US expansion, as well as…

Other Topics

India

M&A

European Biotech

Cell & Gene Therapy

R&D Section Page